Author:
El-Gendy Nashwa,Bertha Craig M.,Abd El-Shafy Mohammed,Gaglani Dhaval K.,Babiskin Andrew,Bielski Elizabeth,Boc Susan,Dhapare Sneha,Fang Lanyan,Feibus Katharine,Kaviratna Anubhav,Li Bing V.,Luke Markham C.,Ma Tian,Newman Bryan,Spagnola Michael,Walenga Ross L.,Zhao Liang
Reference155 articles.
1. FDA, Draft Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Products – Quality Considerations, (2018). When final, this guidance will represent the FDA’s current thinking on this topic. For the most recent version of a guidance, check the FDA guidance web page at https://www.fda.gov/regulatory-information/search-fda-guidance-documents.
2. FDA, Guidance for Industry and FDA staff: current good manufacturing practice requirements for combination products, (2017).
3. The inhalation device influences lung deposition and bronchodilating effect of terbutaline;Borgström;Am. J. Respir. Crit. Care Med.,1996
4. Latest advances in the development of dry powder inhalers;Ashurst;Pharm. sci. technol. today,2000
5. Analysis of polycyclic aromatic hydrocarbons in metered dose inhaler drug formulations by isotope dilution gas chromatography/mass spectrometry;Norwood;J. Pharm. Biomed. Anal.,1995
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献